Akèy › Limfòm folikilè › Kalifòni › Baldwin Park
Etid klinik pou Limfòm folikilè nan Baldwin Park, CA
16 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Ap rekriteFaz 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Ap rekriteFaz 2/3
- City of Hope - Duarte Cancer Center ( Site 1301), Duarte · 4 mi lwen
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Ap rekriteFaz 2
- Research Site, Duarte · 4 mi lwen
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Ap rekriteFaz 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Ap rekriteFaz 1/2
- City of Hope, Duarte · 4 mi lwen
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Ap rekriteFaz 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Ap rekriteFaz 1/2
- City of Hope, Duarte · 4 mi lwen
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Duarte · 4 mi lwen
Etid Limfòm folikilè nan lòt vil
- New York City, NY24 etid
- Milwaukee, WI19 etid
- Nashville, TN18 etid
- Houston, TX18 etid
- Boston, MA17 etid
- Seattle, WA15 etid
- Durham, NC15 etid
- Columbus, OH13 etid
- Salt Lake City, UT13 etid
- Chicago, IL12 etid
- San Antonio, TX12 etid
- Philadelphia, PA12 etid
Lòt etid nan Baldwin Park
- Kansè nan tete45 etid
- Leksemi mieloïd egi40 etid
- Kansè kolorektal38 etid
- Kansè Poumon ki pa ti selil36 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat30 etid
- Kansè Metastatik30 etid
- Sendwòm myelodisplastik26 etid
- Kansè ovè25 etid
- Kansè poumon24 etid
- Myelom Miltip23 etid
- Kansè lestomak22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.